attenuated vaccinations, other than influenza vaccination, until the next rituximab administration is due, and delaying rituximab for 2 weeks after vaccination, is conditionally recommended. Influenza vaccine responses are greater when the vaccine is administered later rather than earlier after rituximab Whether to administer non-live attenuated vaccinations to patients receiving glucocorticoids or with active disease (Table 4 Glucocorticoids Whether to administer non-live attenuated